Ariosa scraps IPO plans, chooses acquisition by Roche
For $400mm up front in cash, Roche Diagnostics Corp. acquired closely held Ariosa Diagnostics Inc., which produces early-stage maternal testing. Roche may also pay up to $225mm in earn-outs. Ariosa had filed for an IPO in March 2014.
- In Vitro Diagnostics
- Laboratory Testing Services
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Payment Includes Cash
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.